Illicit Drug Use
11
1
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care
Addressing Barriers to Care for Substance Use Disorder Pilot Study
An Initial Study of the Implementation of Digital Therapeutics for Substance Use Disorders in Primary Care
Transmission of Tuberculosis Among Illicit Drug Use Linkages
MATAspire: Mental Health Awareness Tailored App for Substance Prevention and Integrated Resilience Education
It´s Up To You: Update and Digitalization of a Universal School-based Prevention Intervention for Drug Initiation and Use
Prospective, Longitudinal Study on FItness DOping in DenmarK
iSTART: A Campus & Community Initiative for Services in Tec-health
ASSIST: A Surveillance Study of Illicit Substance Toxicity
The Follow-up Study for the Patients of Illicit Substance Use Disorder
Hepatitis C Treatment in Underserved Populations